Keeping up with the clinical advances: tardive dyskinesia. [Review] 

 -  2019 
<br/><br/> Tardive dyskinesia (TD) was first described in 1964, but treatment for this sometimes poorly characterized condition lagged decades as it was labored by medico-legal implications. TD has often been lumped with other medication-induced disorders and incorrectly classified as extrapyramidal symptoms. TD is likely to be under-recognized for many of these reasons. Though diverse in its presentations, TD is distinct in terms of time course, pathophysiology, and phenomenology. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1092-8529 
<br/><br/><label>Standard No.: </label>10.1017/S1092852919001263 [doi] S1092852919001263 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Tardive Dyskinesia/dt [Drug Therapy]<br/>Humans<br/>Tardive Dyskinesia/di [Diagnosis]
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Union Memorial Hospital
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article